At disease onset and paralysis, both GFAP and PAD2 expression were increased significantly and were at the highest levels at the paralysis stage in the ALS models (Fig. 4B–G; Additional file 2: Fig. S4). This evidence concerns the gene GFAP and amyotrophic lateral sclerosis.